[1] Kurinczuk JJ,White-Koning M,Badawi N.Epidemiology of neonatal encephalopathy and hypoxic-ischaemic encephalopathy[J].Early Hum Dev,2010,86(6):329-338. [2] Gadzinowski J,Gulczyńska E,Michniewicz B,et al.The use of therapeutic whole body cooling in treating hypoxic-ischemic encephalopathy in the newborn the first case in Poland[J].Ginekol Pol,2012,83(8):630-632. [3] 邵肖梅,叶鸿瑁,丘小汕.实用新生儿学[J].4版.北京:人民卫生出版社,2011:700-706. [4] Drury PP,Bennet L,Gunn AJ.Mechanisms of hypothermic neuroprotection[J].Semin Fetal Neonatal Med,2010,15:287-292. [5] Petzold A.Glialfibrillary acidic protein is a body fluid biomarker for glial pathology in human disease[J].Brain Res,2015,1600:17-31. [6] Bauer AT,Bürgers HF,RabieT,et al.Matrix metalloproteinase-9 mediates hypoxia-induced vascular leakage in the brain via tight junction rearrangement[J].J Cereb Blood Flow Metab,2010,30(4):837-48. [7] Teunissen CE,TumaniH,BennettJL,et al.Consensus Guidelines for CSF and Blood Biobanking for CNS Biomarker Studies[J].Mult Scler Int,2011,18(6):e1-9. [8] ShalakL,PerlmanJM.Hypoxic-ischemic brain injury in the term infant-current concepts[J].Early Hum Dev,2004,80(20):125-141. [9] 王钰,尹晓娟.新生儿缺氧缺血性脑损伤潜在的靶向治疗[J].中华临床医师杂志,2013,28(5),352-355. [10] DupontTL,ChalakLF,Morriss MC,et al.Short-term outcomes of newborns with perinatal acidemia who are not eligible for systemic hypothermia therapy[J].J Pediatr,2013,162(1):35-41. [11] Savage WJ,EverettAD.Biomarkers in pediatrics:children as biomarker orphans[J].Proteomics Clin Appl,2010,4(12):915-921. [12] Nissi R,Talvensaari-Mattila A,Kotila V,et al.Circulating matrix metalloproteinase MMP-9 and MMP-2/TIMP-2 complex are associated with spontaneous early pregnancyfailure[J].Reprod Biol Endocrinol,2013,11(2):e1-6. [13] Brackmann FA,Link AS,Jung S,et al.Activin A regulation under global hypoxia in developing mouse brain[J].Brain Res,2013,1531(19):65-74. |